MedTrace Logo

ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects

NCT00437775 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2007-02-21

No results posted yet for this study

Summary

Proteinuria is an expression of diabetic nephropaty in type 1 and type 2 patients. Hypertenshion treatment and decreasing urine protein excretion, slow down renal deterioration. Treating diabetic ,hypertensive patients with Angiotensin Converting Enzyme inhibitors (ACEi), Angiotensin receptor blockers (ARBs)is common practice. The aim of our work is to examine 1.The prevalence of ACE and ARB treatment in diabetic patients with or without hypertension.2. Adverse drug reactions of ACEi and ARBs alone or in combination.

Conditions

  • Diabetes Mellitus Type 2

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Ahuva Golik, Assoc. Prof. · Sackler School of Medicine, Tel-Aviv University

  • Alina Alperovich, B.Pharm · Assaf-Harofeh Medical Center

  • Lila Akivison, MSc.Pharm · Assaf-Harofeh Medical Center

  • Sofia Berkovitch, MSc. Pharm · Assaf-Harofeh Medical Center

  • Gabby Elbaz, MD · Assaf- Hrofech Medical Senter

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2007-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00437775 on ClinicalTrials.gov